Verition Fund Management LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1454027
GREENWICH, CT
Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
502,200
+3474.4% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Derivatives in ESPR
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
41,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $29,871,201 across 13 Drug Manufacturers - Specialty & Generic names. ESPR ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
40,988 | $6,908,117 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
250,000 | $6,152,500 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
500,000 | $4,915,000 | |
| 4 | LQDA |
Liquidia Corp
|
45,233 | $3,606,427 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
97,363 | $3,375,575 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,675 | $1,991,225 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
15,000 | $1,664,100 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,500 | $479,625 |
All Filings in ESPR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 502,200 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | — | 14,050 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | — | 14,050 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | — | 14,050 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | — | 30,510 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | — | 14,050 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | — | 14,050 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | — | 14,050 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | — | 41,000 | Call | Other | 2024-05-14 | |
| 2024-03-31 | — | 14,050 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | — | 14,050 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | — | 89,050 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | — | 150,695 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | — | 54,406 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | — | 15,250 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | — | 33,920 | Shares | Sole | 2023-01-18 | |
| 2022-06-30 | — | 16,800 | Shares | Sole | 2022-08-30 | |
| No filing history on record for this holder in this stock. | ||||||